DocWire News (@mydocwire) 's Twitter Profile
DocWire News

@mydocwire

DocWire News delivers the most relevant medical news to over 1M HCPs daily.

ID: 857247500578762752

linkhttps://www.docwirenews.com/ calendar_today26-04-2017 14:58:25

8,8K Tweet

2,2K Followers

2,2K Following

DocWire News (@mydocwire) 's Twitter Profile Photo

๐Ÿ” #Obesity isn't just about choicesโ€”it's a chronic disease. ๐Ÿงฌ Itโ€™s time to shift the narrative and treat it with empathy, science, and support. ๐Ÿ“– Dive into this eye-opening read: buff.ly/VmVLdf5 #ObesityAwareness #ChronicDisease #HealthcareMatters #EndStigma

๐Ÿ” #Obesity isn't just about choicesโ€”it's a chronic disease.
๐Ÿงฌ Itโ€™s time to shift the narrative and treat it with empathy, science, and support.
๐Ÿ“– Dive into this eye-opening read: buff.ly/VmVLdf5

#ObesityAwareness #ChronicDisease #HealthcareMatters #EndStigma
DocWire News (@mydocwire) 's Twitter Profile Photo

๐Ÿงฌ Exciting news in dermatology! Upadacitinib shows promise for treating hidradenitis suppurativa. ๐Ÿ“Š In a phase 2 trial, 38.3% achieved HiSCR50 at week 12 vs. 25% with placebo. ๐Ÿ”— buff.ly/BEW2lJZ #HidradenitisSuppurativa #Upadacitinib #Dermatology #ClinicalTrials

๐Ÿงฌ Exciting news in dermatology! Upadacitinib shows promise for treating hidradenitis suppurativa.
๐Ÿ“Š In a phase 2 trial, 38.3% achieved HiSCR50 at week 12 vs. 25% with placebo.
๐Ÿ”— buff.ly/BEW2lJZ
#HidradenitisSuppurativa #Upadacitinib #Dermatology #ClinicalTrials
DocWire News (@mydocwire) 's Twitter Profile Photo

๐Ÿšจ New eczema research is in! ๐Ÿ” Find out who benefits most from #lebrikizumab and when. ๐Ÿ‘‰ Read more: buff.ly/HOxWrFg #Eczema #Dermatology #Lebrikizumab #HealthNews #SkinCare

๐Ÿšจ New eczema research is in!
๐Ÿ” Find out who benefits most from #lebrikizumab and when.
๐Ÿ‘‰ Read more: buff.ly/HOxWrFg

#Eczema #Dermatology #Lebrikizumab #HealthNews #SkinCare
DocWire News (@mydocwire) 's Twitter Profile Photo

#ASCO25 ๐Ÿš€ ๐Ÿงฌ New research reveals how #organoids provide key insight into #melanoma drug resistance. ๐Ÿงช Could this be a turning point in personalized cancer therapies? ๐Ÿ”— buff.ly/vkOLnvQ #CancerResearch #Melanoma #Organoids #DrugResistance #Oncology

#ASCO25 ๐Ÿš€  
๐Ÿงฌ New research reveals how #organoids provide key insight into #melanoma drug resistance.  
๐Ÿงช Could this be a turning point in personalized cancer therapies?  
๐Ÿ”— buff.ly/vkOLnvQ  
#CancerResearch #Melanoma #Organoids #DrugResistance #Oncology
DocWire News (@mydocwire) 's Twitter Profile Photo

#ASCO25 ๐Ÿฉบ ๐Ÿ“Š New data highlight clinical predictors of early #cutaneousmelanoma recurrence. ๐Ÿ“ˆ Key variables may guide post-treatment surveillance and decision-making. ๐Ÿ”— buff.ly/dznq8Ka #Melanoma #Oncology #CancerRecurrence #ClinicalResearch #SkinCancer #DermOnc

#ASCO25 ๐Ÿฉบ  
๐Ÿ“Š New data highlight clinical predictors of early #cutaneousmelanoma recurrence.  
๐Ÿ“ˆ Key variables may guide post-treatment surveillance and decision-making.  
๐Ÿ”— buff.ly/dznq8Ka  
#Melanoma #Oncology #CancerRecurrence #ClinicalResearch #SkinCancer #DermOnc
DocWire News (@mydocwire) 's Twitter Profile Photo

๐Ÿšจ New research presented at #ASCO25 out of Memorial Sloan Kettering Cancer Center: ๐Ÿงฌ #Papsmear #ctDNA allows for earlier identification of #endometrialcancer ๐Ÿ”— Read more: buff.ly/VEiTufb #ctDNA #CancerDetection #EarlyDiagnosis #WomensHealth #MedicalInnovation #LiquidBiopsy

๐Ÿšจ New research presented at #ASCO25 out of <a href="/MSKCancerCenter/">Memorial Sloan Kettering Cancer Center</a>:
๐Ÿงฌ #Papsmear #ctDNA allows for earlier identification of #endometrialcancer
๐Ÿ”— Read more: buff.ly/VEiTufb
#ctDNA #CancerDetection #EarlyDiagnosis #WomensHealth #MedicalInnovation #LiquidBiopsy
DocWire News (@mydocwire) 's Twitter Profile Photo

๐Ÿ”ฌ #ASCO25 ๐Ÿ“ˆ Concurrent chemoradiotherapy (CCRT) shows superior outcomes ๐Ÿงช CCRT outperforms radiotherapy and surgery in overall and progression-free survival ๐Ÿ’ก Combining CCRT with other therapies offers comparable efficacy ๐Ÿ”— Read more: buff.ly/Cra55Vv

๐Ÿ”ฌ #ASCO25
๐Ÿ“ˆ Concurrent chemoradiotherapy (CCRT) shows superior outcomes
๐Ÿงช CCRT outperforms radiotherapy and surgery in overall and progression-free survival
๐Ÿ’ก Combining CCRT with other therapies offers comparable efficacy
๐Ÿ”— Read more: buff.ly/Cra55Vv
DocWire News (@mydocwire) 's Twitter Profile Photo

๐Ÿงฌ A new study from #ASCO25 explores neoadjuvant #pepinemab in #headandneckcancer treatment ๐Ÿ”ฌ Aims to prime #tumor immunity before surgical intervention ๐Ÿ“ˆ Potentially enhancing patient outcomes through immune activation ๐Ÿ”— Read more: buff.ly/ej6hM9Q

๐Ÿงฌ A new study from #ASCO25 explores neoadjuvant #pepinemab in #headandneckcancer treatment
๐Ÿ”ฌ Aims to prime #tumor immunity before surgical intervention
๐Ÿ“ˆ Potentially enhancing patient outcomes through immune activation
๐Ÿ”— Read more: buff.ly/ej6hM9Q
DocWire News (@mydocwire) 's Twitter Profile Photo

๐Ÿงฌ๐Ÿ” New insights into #uterine #leiomyosarcoma! A study presented at #ASCO25 analyzes the genetic profile of LMS using a national database. ๐Ÿ“„ Read more: buff.ly/c5D5GES #UterineCancer #GenomicProfiling #CancerResearch #ASCO25

๐Ÿงฌ๐Ÿ” New insights into #uterine #leiomyosarcoma!

A study presented at #ASCO25 analyzes the genetic profile of LMS using a national database.

๐Ÿ“„ Read more: buff.ly/c5D5GES

#UterineCancer #GenomicProfiling #CancerResearch #ASCO25
DocWire News (@mydocwire) 's Twitter Profile Photo

๐Ÿงฌ A new study examines pembrolizumab plus lenvatinib in uterine carcinosarcoma ๐Ÿ“Š Results were shared at #ASCO25, highlighting clinical benefit in select patients ๐Ÿ”— buff.ly/My4e4f1 #UterineCancer #Immunotherapy #CancerResearch #ASCO25

๐Ÿงฌ A new study examines pembrolizumab plus lenvatinib in uterine carcinosarcoma
๐Ÿ“Š Results were shared at #ASCO25, highlighting clinical benefit in select patients
๐Ÿ”— buff.ly/My4e4f1
#UterineCancer #Immunotherapy #CancerResearch #ASCO25
DocWire News (@mydocwire) 's Twitter Profile Photo

๐Ÿ’Š 71% of patients with sleep disorders preferred solriamfetol over modafinils in a real-world study. ๐Ÿ”„ Those who switched back cited better results or fewer side effects with modafinils. ๐Ÿ”— Read more: buff.ly/s8IF3HY #SleepHealth #Narcolepsy #Solriamfetol #Modafinil

๐Ÿ’Š 71% of patients with sleep disorders preferred solriamfetol over modafinils in a real-world study.
๐Ÿ”„ Those who switched back cited better results or fewer side effects with modafinils.
๐Ÿ”— Read more: buff.ly/s8IF3HY
#SleepHealth #Narcolepsy #Solriamfetol #Modafinil
DocWire News (@mydocwire) 's Twitter Profile Photo

๐Ÿง  REM sleep apnea may be more harmful than we thoughtโ€”it's linked to white matter changes and cognitive decline. ๐Ÿ˜ด A deeper look into how sleep phases impact brain health. ๐Ÿ”— buff.ly/1pUiUSP #SleepHealth #BrainResearch #REM #SleepApnea #Cognition

๐Ÿง  REM sleep apnea may be more harmful than we thoughtโ€”it's linked to white matter changes and cognitive decline.
๐Ÿ˜ด A deeper look into how sleep phases impact brain health.
๐Ÿ”— buff.ly/1pUiUSP
#SleepHealth #BrainResearch #REM #SleepApnea #Cognition
DocWire News (@mydocwire) 's Twitter Profile Photo

๐ŸŽฅ Did you know TikTok is reshaping conversations about #irritableboweldisease? ๐ŸŒ Patients are turning to social media to connect, learn, & find community. ๐Ÿ”— Read more here: buff.ly/r5WJ3ck #IBDAwareness #Crohns #UlcerativeColitis #Healthcare

๐ŸŽฅ Did you know TikTok is reshaping conversations about #irritableboweldisease?
๐ŸŒ Patients are turning to social media to connect, learn, &amp; find community.
๐Ÿ”— Read more here: buff.ly/r5WJ3ck
#IBDAwareness #Crohns #UlcerativeColitis #Healthcare
DocWire News (@mydocwire) 's Twitter Profile Photo

๐Ÿฅผ Mediterranean vs. low-FODMAP: Which diet better supports IBS symptom control in clinical practice? ๐Ÿ“Š New comparative data offers insights into efficacy and long-term feasibility. buff.ly/jLV1a6D #IBS #Gastroenterology #MedTwitter #NutritionScience #EvidenceBased

๐Ÿฅผ Mediterranean vs. low-FODMAP: Which diet better supports IBS symptom control in clinical practice?
๐Ÿ“Š New comparative data offers insights into efficacy and long-term feasibility.
buff.ly/jLV1a6D
#IBS #Gastroenterology #MedTwitter #NutritionScience #EvidenceBased
DocWire News (@mydocwire) 's Twitter Profile Photo

๐Ÿ‘ถ New study links paternal psychological distress to delays in early child development ๐Ÿง  Impacts seen as early as 12 months ๐Ÿ’ก Highlights the need for paternal mental health screening ๐Ÿ”— buff.ly/QlZrIRX #ChildDevelopment #MentalHealth #Pediatrics #PublicHealth

๐Ÿ‘ถ New study links paternal psychological distress to delays in early child development
๐Ÿง  Impacts seen as early as 12 months
๐Ÿ’ก Highlights the need for paternal mental health screening
๐Ÿ”— buff.ly/QlZrIRX
#ChildDevelopment #MentalHealth #Pediatrics #PublicHealth
DocWire News (@mydocwire) 's Twitter Profile Photo

๐Ÿถ Can dogs help prevent eczema in kids with genetic risk? ๐Ÿงฌ New research says early-life dog exposure may reduce eczema riskโ€”even in those genetically predisposed. ๐Ÿ“– Dive into the findings: buff.ly/TAHNxJl #Eczema #Pediatrics #AllergyPrevention #Genetics

๐Ÿถ Can dogs help prevent eczema in kids with genetic risk?
๐Ÿงฌ New research says early-life dog exposure may reduce eczema riskโ€”even in those genetically predisposed.
๐Ÿ“– Dive into the findings: buff.ly/TAHNxJl
#Eczema #Pediatrics #AllergyPrevention #Genetics
DocWire News (@mydocwire) 's Twitter Profile Photo

๐Ÿšจ U.S. FDA has approved #dupilumab for #bullouspemphigoid ๐ŸŽฏ 18.3% achieved sustained remission ๐Ÿงช Less steroid use, less itch, better outcomes ๐Ÿ”— buff.ly/VtfRuzH #Dermatology #FDAapproval

๐Ÿšจ <a href="/US_FDA/">U.S. FDA</a> has approved #dupilumab for #bullouspemphigoid
๐ŸŽฏ 18.3% achieved sustained remission
๐Ÿงช Less steroid use, less itch, better outcomes
๐Ÿ”— buff.ly/VtfRuzH
#Dermatology #FDAapproval
DocWire News (@mydocwire) 's Twitter Profile Photo

โš ๏ธ New study links central obesity to higher psoriasis risk ๐Ÿ“ Waist circumference may be more telling than BMI ๐Ÿงฌ Highlights need for targeted screening & prevention ๐Ÿ”— buff.ly/nPB2jku #Psoriasis #Obesity #Inflammation #Dermatology #ChronicDisease

โš ๏ธ New study links central obesity to higher psoriasis risk
๐Ÿ“ Waist circumference may be more telling than BMI
๐Ÿงฌ Highlights need for targeted screening &amp; prevention
๐Ÿ”— buff.ly/nPB2jku
#Psoriasis #Obesity #Inflammation #Dermatology #ChronicDisease
DocWire News (@mydocwire) 's Twitter Profile Photo

IBD โ‰  pneumonia riskโ€”unless other factors are at play. A new study shows comorbidities (12x) and steroid use (2x) are the real drivers of pneumonia in IBDโ€”not the disease itself. buff.ly/TkwsIlY #IBD #InfectionRisk #Pneumonia

IBD โ‰  pneumonia riskโ€”unless other factors are at play.

A new study shows comorbidities (12x) and steroid use (2x) are the real drivers of pneumonia in IBDโ€”not the disease itself.
buff.ly/TkwsIlY 
#IBD #InfectionRisk #Pneumonia
DocWire News (@mydocwire) 's Twitter Profile Photo

TikTok skin care for kids may be harmingโ€”not helping. Findings: ๐Ÿšซ Only 26% used SPF โš ๏ธ 11+ irritating actives/video ๐Ÿคณ Often push โ€œlighter, brighterโ€ skin ideals Is this beauty or harm disguised as health? buff.ly/2MyPSMF #Skincare #Pediatrics #TikTok

TikTok skin care for kids may be harmingโ€”not helping.

Findings: 

๐Ÿšซ Only 26% used SPF
โš ๏ธ 11+ irritating actives/video
๐Ÿคณ Often push โ€œlighter, brighterโ€ skin ideals

Is this beauty or harm disguised as health?

buff.ly/2MyPSMF 

#Skincare #Pediatrics #TikTok